STAT
JANUARY 23, 2024
The head of the Abortion Fund of Ohio had a sinking feeling as she looked at its end-of-year finances last month. The fund had paid out $1.5 million in 2023 to help close to 4,400 patients get abortions — up from 1,175 the year before — and the pace wasn’t sustainable. If the fund didn’t take a pause for a few weeks, she feared it would run out of money and have to close for good.
PharmaVoice
JANUARY 23, 2024
What started as an examination of the Human Foods Program has expanded into an agency-wide overhaul.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JANUARY 23, 2024
Millions of American women over age 40 receive regular mammograms to screen for breast cancer. About half of them turn out to have dense breast tissue — which makes screening significantly more complicated. “It’s kind of a double whammy because dense breast tissue not only makes cancers harder to find, but people with denser tissue are more likely to get breast cancer,” said Laurie Margolies, a radiologist and vice chair for breast imaging at Mount Sinai.
The Pharmacist
JANUARY 23, 2024
Recommendations made to the parliamentary pharmacy inquiry include giving greater powers to non-prescribing pharmacists to vary prescriptions and freeing up pharmacists for a more clinical, patient-facing role. Speaking to the health and social care committee (HSCC) last week, the chief executive of the General Pharmaceutical Council (GPhC) suggested that changes needed to be made to […] The post Don’t forget clinical capacity of non-prescribers, urges GPhC appeared first on The Pharmacist
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
JANUARY 23, 2024
LONDON — In a bid to expand its pipeline of inflammation-targeting drugs, Sanofi said Tuesday it was acquiring California-based Inhibrx in a deal worth up to $2.2 billion. The core of the deal is Inhibrx’s experimental therapy for AATD, a disease that progressively damages the lungs and liver. The medicine, INBRX-101, is designed to reduce inflammation and stave off further damage to the tissue.
BioPharma Dive
JANUARY 23, 2024
A black box warning for secondary T cell malignancies should be added to the labeling of all six approved CAR-T therapies, the agency said.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Pharmaceutical Commerce
JANUARY 23, 2024
Study describes how a game theoretic model can successfully analyze how adoption of blockchain technology can reveal quality information.
STAT
JANUARY 23, 2024
Good morning, everyone, and how are you today? We are doing just fine, thank you, despite some cloudy skies hovering overhead. Given that a much-welcomed thaw, of sorts, is under way, there is no need to complain. Of course, some subscribe to the notion that to live is to complain, but we will ignore the philosophers today. Instead, we will reach for another delicious cup of stimulation to brighten our mood.
pharmaphorum
JANUARY 23, 2024
Two artificial intelligence-powered software tools – e-Stroke and RapidAI – have been recommended for use in the NHS to help detect stroke from CT brain scans by NICE. The health technology assessment (HTA) agency said there is some evidence that people admitted to hospital with a suspected had faster or better access to treatment after using the software, although for now it is unclear whether that was a direct consequence of the digital technology.
STAT
JANUARY 23, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello, everyone. Damian here with a look at some polarizing cancer data, a strange CEO transition, and the importance of New Year cheer.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
The Pharmacist
JANUARY 23, 2024
Patient safety and wellbeing is ‘inextricably bound up’ with the wellbeing of the profession, the chief executive of the General Pharmaceutical Council (GPhC) has told MPs. Duncan Rudkin made the comments as part of an evidence session to the Health and Social Care Committee’s pharmacy inquiry, where together with other pharmacy representatives, he highlighted pressures […] The post Pharmacist wellbeing ‘has patient safety implications' appeared first on The Pharmacist.
STAT
JANUARY 23, 2024
Steward Health Care, a for-profit health system that serves thousands of patients in Eastern Massachusetts, is in such grave financial distress that it may be unable to continue operating some facilities, according to public records and people with knowledge of the situation. The fast-moving crisis has left regulators racing to prevent the massive layoffs and erosion of care that could come if hospital services were to suddenly cease.
Express Pharma
JANUARY 23, 2024
The Serum Institute of India (SII), is joining a CEPI network of vaccine producers in the Global South to support more rapid, agile, and equitable responses to future public health disease outbreaks. The addition of SII to the CEPI manufacturing network will be a significant boost to vaccine production efforts in Global South regions and will mean the world is better prepared to achieve the 100 Days Mission to develop new vaccines against known or novel infectious diseases within three months of
European Pharmaceutical Review
JANUARY 23, 2024
As a tool for detecting and identifying bacteria, aptamers are a promising new class of synthetic nucleic acid molecules that can be used to detect and treat of pathogenic bacteria. With the ability to be developed against a whole bacterium, a microbial toxin, or some proteins, for some bacteria, “aptamers against pathogens can not only supplement the deficiency of antibodies but can also enrich the aptamer database to develop efficient analytical regents”, according to a paper published in the
pharmaphorum
JANUARY 23, 2024
Study finds evidence that an AlZpath immunoassay for phosphorylated tau could deliver an effective blood test for Alzheimer's, paving the way for screening and early treatment
Pharma Times
JANUARY 23, 2024
The advancement could allow earlier detection of cancer in the blood and better treatment
pharmaphorum
JANUARY 23, 2024
Eli Lilly’s gene therapy for otoferlin-related deafness has restored the hearing of the first child enrolled in its ongoing phase 1/2 trial
Pharma Times
JANUARY 23, 2024
Autosomal dominant polycystic kidney disease affects more than 12 million people globally
pharmaphorum
JANUARY 23, 2024
Bringing clinical trials to patients has become easier with the advent of digital technologies and decentralised clinical trials (DCTs). Learn how the hybrid approach combining traditional and digital methods can benefit patients and advance medical research.
Pharmaceutical Technology
JANUARY 23, 2024
The UK MHRA has introduced further restrictions on the usage of fluoroquinolone antibiotics, strengthening the previous regulations.
pharmaphorum
JANUARY 23, 2024
Sanofi agrees $2.2bn deal to buy California biotech Inhibrx and its long-acting therapy for rare disease AATD, which causes life-threatening emphysema.
Express Pharma
JANUARY 23, 2024
The field of sustainable nutrition is redefining the global food landscape by merging traditional dietary practices with innovative technologies. This evolution, driven by the urgent need for environmental sustainability and enhanced health benefits, is spotlighting alternative food sources and advanced production methods. This transformative trend is not just a fleeting movement but a crucial pivot towards a more sustainable future, finds GlobalData.
World Pharma News
JANUARY 23, 2024
The Bayer Group is introducing a new operating model called "Dynamic Shared Ownership" (DSO) worldwide, which will reduce hierarchies, eliminate bureaucracy, streamline structures and accelerate decision-making processes. The aim of the new operating model is to make the company much more agile and significantly improve its operational performance.
The Pharmacist
JANUARY 23, 2024
People not having all their recommended doses of the Covid vaccine led to thousands of unnecessary deaths and severe outcomes, researchers have found. Over 7,000 hospitalisations and deaths might have been avoided in summer 2022 if there had been ‘full’ Covid-19 vaccination coverage across the UK, according to a new study. Using health record data […] The post Covid undervaccination led to thousands of deaths in UK appeared first on The Pharmacist.
Outsourcing Pharma
JANUARY 23, 2024
Manufacturer for the pharma and life sciences industry, Gerresheimer, is investing more than $88 million to expand its operations in Peachtree City, Georgia.
Pharmaceutical Technology
JANUARY 23, 2024
Genentech will utilise GenEdit’s non-viral polymer nanoparticles for gene therapy delivery in autoimmune diseases.
pharmaphorum
JANUARY 23, 2024
Ukraine-based digital pharma marketing specialist Viseven gets private equity investment from Horizon Capital
Express Pharma
JANUARY 23, 2024
Lupin has received tentative approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application for Rivaroxaban Tablets USP, 2.5 mg, 10 mg, 15 mg, and 20 mg, to market a generic equivalent of Xarelto Tablets, 2.5 mg, 10 mg, 15 mg, and 20 mg, of Janssen Pharmaceuticals. This product will be manufactured at Lupin’s Pithampur facility in India.
pharmaphorum
JANUARY 23, 2024
In this new episode of the pharmaphorum podcast, web editor Nicole Raleigh welcomes guest Cem Zorluhar, CEO of Er-Kim Pharmaceuticals, for a conversation on antimicrobial resistance (AMR) and what the biotech industry should be focussing on in order to address this critical issue outside of the West.
Outsourcing Pharma
JANUARY 23, 2024
Yesterday (January 22), Saama announced the release of several âgroundbreakingâ features within its AI-driven platform, including generative AI (GenAI) chat and interactive review listings (IRL), that it says create a workflow-driven environment for cross-functional collaboration.
The Pharmacist
JANUARY 23, 2024
Attending an NHS Health Check is associated with a lower risk of both death and several diseases, according to a new study. An observational study using UK Biobank participants, published today, found that among those who took up an NHS Health check there was a 19% lower rate of dementia diagnosis and 23% lower risk […] The post Attending NHS Health Check linked to ‘significantly lower risk of disease’ appeared first on The Pharmacist.
Outsourcing Pharma
JANUARY 23, 2024
Sano Genetics says it is developing software that will enable âthe precision medicine revolutionâ and has raised $11.4 million in new funding.
Pharmafile
JANUARY 23, 2024
Sanofi and Inhibrx, Inc have announced that they have entered into a definitive agreement for Sanofi to acquire Inhibrx following the spin-off of non-INBRX-101 assets into New Inhibrx. INBRX-101 is a human recombinant protein for the treatment of patients with Alpha-1 Antitrypsin Deficiency (AATD), allowing them to achieve normalisation of serum AAT levels with less […] The post Sanofi to acquire Inhibrx for approximately $1.7bn appeared first on Pharmafile.
BioPharma Dive
JANUARY 23, 2024
The acquisition will give Sanofi an experimental drug for alpha-1 antitrypsin deficiency, while the rest of Inhibrx's assets will be spun out into a new company.
Drug Patent Watch
JANUARY 23, 2024
Annual Drug Patent Expirations for DIFICID Dificid is a drug marketed by Cubist Pharms Llc and is included in two NDAs. It is available from one supplier. There are six… The post New patent for Cubist Pharms drug DIFICID appeared first on DrugPatentWatch - Make Better Decisions.
Expert insights. Personalized for you.
352 
Let's personalize your content